Meeting of the Advisory Committee on Blood Safety and Availability, 45051 [E7-15682]

Download as PDF Federal Register / Vol. 72, No. 154 / Friday, August 10, 2007 / Notices in paper form, and the first page of the document must be clearly labeled ‘‘Confidential.’’ 1 The FTC is requesting that any comment filed in paper form be sent by courier or overnight service, if possible. Comments filed in electronic form should be submitted by using the following Weblink: https:// secure.commentworks.com/ftcwarrantypra (and following the instructions on the Web-based form). To ensure that the Commission considers an electronic comment, you must file it on the Web-based form at the Weblink: https://secure.commentworks.com/ftcwarrantypra. If this notice appears at https://www.regulations.gov, you may also file an electronic comment through that Web site. The Commission will consider all comments that regulations.gov forwards to it. The FTC Act and other laws the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. All timely and responsive public comments will be considered by the Commission, and will be available to the public on the FTC Web site, to the extent practicable, at httpa:// www.ftc.gov. As a matter of discretion, the FTC makes every effort to remove home contact information for individuals from the public comments it receives before placing those comments on the FTC Web site. More information, including routine uses permitted by the Privacy Act, may be found in the FTC’s privacy policy, at https://www.ftc.gov/ ftc/privacy.htm. Richard C. Donohue, Acting Secretary. [FR Doc. E7–15695 Filed 8–9–07; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Blood Safety and Availability Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: sroberts on PROD1PC70 with PROPOSALS SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 1 Commission Rule 4.2(d), 16 CFR 4.2(d). The comment must be accompanied by an explicit request for confidential treatment, including the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. The request will be granted or denied by the Commission’s General Counsel, consistent with applicable law and the public interest. See Commission Rule 4.9(c), 16 CFR 4.9(c). VerDate Aug<31>2005 16:37 Aug 09, 2007 Jkt 211001 45051 Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood Safety and Availability (ACBSA) will hold a meeting. The meeting will be open to the public on both Wednesday, August 22 and Thursday, August 23, 2007. DEPARTMENT OF HEALTH AND HUMAN SERVICES The meeting will take place Wednesday, August 22, 2007 and Thursday, August 23, 2007 from 9 a.m. to 5 p.m. Agency Information Collection Activities: Proposed Collection; Comment Request DATES: Georgetown University Conference Center, 3800 Reservoir Road, NW., Washington, DC 20057 ADDRESSES: Jerry A. Holmberg, PhD, Executive Secretary, Advisory Committee on Blood Safety and Availability, Office of Public Health and Science, Department of Health and Human Services, 1101 Wootton Parkway, Room 250, Rockville, MD 20852, (240) 453–8803, fax (240) 453– 8456, e-mail ACBSA@hhs.gov. FOR FURTHER INFORMATION CONTACT: The ACBSA will discuss ethical considerations and risk benefits for ensuring transfusion and transplantation safety during focal periods of shortages. In addition the Committee will review and discuss the elasticity of the blood supply to support transfusion and transplantation safety as well as strategies and barriers to those strategies. Public comment will be solicited on both August 22 and 23, 2007. Comments will be limited to five minutes per speaker. Anyone planning to comment is encouraged to contact the Executive Secretary at his/her earliest convenience. Those who wish to have printed material distributed to Advisory Committee members should submit thirty (30) copies to the Executive Secretary prior to close of business August 17, 2007. Likewise, those who wish to utilize electronic data projection to the Committee must submit their materials to the Executive Secretary prior to close of business August 17, 2007. SUPPLEMENTARY INFORMATION: Dated: July 26, 2007. Richard A. Henry, Deputy Executive Secretary, Advisory Committee on Blood Safety and Availability. [FR Doc. E7–15682 Filed 8–9–07; 8:45 am] BILLING CODE 4150–41–P PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Centers for Medicare & Medicaid Services [Document Identifier: CMS–R–118 and CMS–2088–92] Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Reinstatement without change of a previously approved collection; Title of Information Collection: Quality Improvement (formerly Peer Review) Organization Contracts: Solicitation of Statements of Interest from In-State Organizations, General Notice and Supporting Regulations in 42 CFR, 475.102, 475.103, 475.104, 475.105, 475.106; Use: The criteria that an organization must satisfy in order to be eligible for a Medicare Quality Improvement Organization (QIO) contract are specified by law and set forth in Sections 1152 and 1153 of the Social Security Act (the Act). In very basic terms, the applicant organization must demonstrate that it is either a physician-sponsored or physicianaccess organization. The qualifications for in-State status for an otherwise qualified QIO organization are also set forth in Section 1153(i) (3) of the Act. To comply with Section 1153 of the Act, we must publish the solicitation of statements of interest from qualified inState organizations no later than January 31, 2008. We wish to publish notice of contract expiration dates and the time periods during which interested, qualified organizations may submit AGENCY: E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 72, Number 154 (Friday, August 10, 2007)]
[Notices]
[Page 45051]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15682]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


 Meeting of the Advisory Committee on Blood Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood Safety and Availability (ACBSA) will 
hold a meeting. The meeting will be open to the public on both 
Wednesday, August 22 and Thursday, August 23, 2007.

DATES: The meeting will take place Wednesday, August 22, 2007 and 
Thursday, August 23, 2007 from 9 a.m. to 5 p.m.

ADDRESSES: Georgetown University Conference Center, 3800 Reservoir 
Road, NW., Washington, DC 20057

FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive 
Secretary, Advisory Committee on Blood Safety and Availability, Office 
of Public Health and Science, Department of Health and Human Services, 
1101 Wootton Parkway, Room 250, Rockville, MD 20852, (240) 453-8803, 
fax (240) 453-8456, e-mail ACBSA@hhs.gov.

SUPPLEMENTARY INFORMATION: The ACBSA will discuss ethical 
considerations and risk benefits for ensuring transfusion and 
transplantation safety during focal periods of shortages. In addition 
the Committee will review and discuss the elasticity of the blood 
supply to support transfusion and transplantation safety as well as 
strategies and barriers to those strategies.
    Public comment will be solicited on both August 22 and 23, 2007. 
Comments will be limited to five minutes per speaker. Anyone planning 
to comment is encouraged to contact the Executive Secretary at his/her 
earliest convenience. Those who wish to have printed material 
distributed to Advisory Committee members should submit thirty (30) 
copies to the Executive Secretary prior to close of business August 17, 
2007. Likewise, those who wish to utilize electronic data projection to 
the Committee must submit their materials to the Executive Secretary 
prior to close of business August 17, 2007.

    Dated: July 26, 2007.
Richard A. Henry,
Deputy Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
 [FR Doc. E7-15682 Filed 8-9-07; 8:45 am]
BILLING CODE 4150-41-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.